Eterna Therapeutics Inc. (ERNA)
NASDAQ
Market Cap
$23.03M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
661 of 951
Rank in Industry
370 of 544
Largest Insider Buys in Sector
ERNA Stock Price History Chart
ERNA Stock Performance
About Eterna Therapeutics Inc.
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics, Inc. is based in Brooklyn, New York.
Insider Activity of Eterna Therapeutics Inc.
Over the last 12 months, insiders at Eterna Therapeutics Inc. have bought $0 and sold $0 worth of Eterna Therapeutics Inc. stock.
On average, over the past 5 years, insiders at Eterna Therapeutics Inc. have bought $10,666.49B and sold $4.77M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 13,252,112 shares for transaction amount of $31,999.46B was made by Cherington Charles (10 percent owner) on 2024‑10‑29.
List of Insider Buy and Sell Transactions, Eterna Therapeutics Inc.
| 2024-10-29 | 10 percent owner | 13.25M – | $2.41M | $31,999.46B | -60.87% | |||
| 2022-12-02 | director | 261,756 3.9322% | $3.28 | $858,560 | -16.36% | |||
| 2022-12-02 | director | 335,920 5.0463% | $3.28 | $1.1M | -16.36% | |||
| 2022-12-02 | director | 283,286 4.2556% | $3.28 | $929,178 | -16.36% | |||
| 2021-07-14 | 10 percent owner | 1 <0.0001% | $11.99 | $12 | -69.43% | |||
| 2021-07-09 | 10 percent owner | 1 <0.0001% | $14.11 | $14 | -70.12% | |||
| 2021-07-08 | 10 percent owner | 1 <0.0001% | $14.35 | $14 | -71.92% | |||
| 2021-07-06 | Sale | 10 percent owner | 75,000 5.5174% | $16.06 | $1.2M | -73.58% | ||
| 2021-06-17 | Sale | 200,000 14.426% | $15.75 | $3.15M | -67.47% | |||
| 2021-06-16 | Sale | 200,000 14.412% | $15.73 | $3.15M | -67.72% | |||
| 2020-08-13 | Sale | 10 percent owner | 327,650 8.3217% | $5.55 | $1.82M | -26.35% | ||
| 2020-06-17 | Sale | 10 percent owner | 12,400 0.3413% | $6.01 | $74,524 | -5.23% | ||
| 2020-06-16 | Sale | 10 percent owner | 100 0.0018% | $3.86 | $386 | -49.67% | ||
| 2020-06-03 | Sale | 10 percent owner | 21,932 0.1102% | $1.10 | $24,059 | +83.75% | ||
| 2020-06-02 | Sale | 10 percent owner | 30,730 0.1393% | $0.99 | $30,423 | +131.05% | ||
| 2020-06-01 | Sale | 10 percent owner | 30,000 0.1455% | $1.06 | $31,770 | +104.67% | ||
| 2020-05-29 | Sale | 10 percent owner | 25,000 0.1211% | $1.06 | $26,450 | +95.09% | ||
| 2020-05-28 | Sale | 10 percent owner | 12,338 0.0611% | $1.08 | $13,350 | +107.62% | ||
| 2020-05-27 | Sale | 10 percent owner | 5,000 0.0254% | $1.11 | $5,540 | +96.40% | ||
| 2020-05-26 | Sale | 10 percent owner | 20,000 0.0998% | $1.09 | $21,780 | +102.80% |
Insider Historical Profitability
<0.0001%
| BROADWOOD PARTNERS, L.P. | 29971561 58.3391% | $0.45 | 15 | 0 | ||
| BRADSHER NEAL C | 9322262 18.1456% | $0.45 | 3 | 0 | ||
| Trinad Capital Master Fund Ltd. | 10 percent owner | 8900093 17.3239% | $0.45 | 41 | 0 | |
| Fidelity National Financial, Inc. | 10 percent owner | 5921811 11.5267% | $0.45 | 0 | 15 | |
| WEST MICHAEL D | Co-Chief Executive Officer | 882864 1.7185% | $0.45 | 3 | 1 | |
| Cherington Charles | director | 556465 1.0831% | $0.45 | 1 | 2 | <0.0001% |
| HALPERN JOHN D | director | 450961 0.8778% | $0.45 | 1 | 0 | <0.0001% |
| BUSH MICHAEL J | CEO | 300478 0.5849% | $0.45 | 14 | 0 | |
| Berg Jeffrey Alan | 10 percent owner | 276100 0.5374% | $0.45 | 26 | 9 | |
| Khuchua Vladimir | EVP and Chief Product Officer | 272700 0.5308% | $0.45 | 4 | 0 | |
| Singer Nicholas Jason | director | 266214 0.5182% | $0.45 | 1 | 0 | <0.0001% |
| AWM Investment Company, Inc. | 10 percent owner | 251562 0.4897% | $0.45 | 0 | 28 | |
| Yanover Paul | director | 205000 0.399% | $0.45 | 2 | 0 | |
| LICHTINGER PEDRO | director | 126250 0.2457% | $0.45 | 2 | 0 | |
| Farricielli Joseph J. Jr. | director | 110000 0.2141% | $0.45 | 15 | 0 | |
| Keymer Kenneth L | director | 98100 0.191% | $0.45 | 3 | 0 | |
| FARRELL STEPHEN C | director | 97450 0.1897% | $0.45 | 6 | 0 | |
| Wolff Allen | CFO and EVP | 95500 0.1859% | $0.45 | 3 | 0 | |
| MOHANTY ADITYA P. | Co-Chief Executive Officer | 89696 0.1746% | $0.45 | 1 | 0 | |
| Santana Dario Loreto | President and CEO | 75000 0.146% | $0.45 | 1 | 0 | |
| Russell Angus C. | director | 67500 0.1314% | $0.45 | 1 | 0 | |
| Simtob Richard Isaac | director | 52088 0.1014% | $0.45 | 3 | 0 | |
| CLASEN ROBERT B | director | 50000 0.0973% | $0.45 | 1 | 0 | |
| SCHLACHET DAVID | director | 32050 0.0624% | $0.45 | 1 | 0 | |
| Bourbiel Jennifer | Vice President, Marketing | 15000 0.0292% | $0.45 | 1 | 0 | |
| Mitgang Steve | director | 15000 0.0292% | $0.45 | 2 | 0 | |
| ARLEN GARY H | director | 10450 0.0203% | $0.45 | 1 | 0 | |
| COHEN ABRAHAM E | director | 10000 0.0195% | $0.45 | 1 | 0 | |
| Lewis Mary Beth | director | 10000 0.0195% | $0.45 | 1 | 0 | |
| Glassman Nicholas A | EVP of Product and Technology | 10000 0.0195% | $0.45 | 1 | 0 | |
| Uphoff Tony | director | 9600 0.0187% | $0.45 | 1 | 0 | |
| GARCIA PETER S | Chief Financial Officer | 7000 0.0136% | $0.45 | 2 | 0 | |
| Krishnan Ram | CEO | 5900 0.0115% | $0.45 | 4 | 0 | |
| Miller Dave Brian | SVP Marketing | 5600 0.0109% | $0.45 | 6 | 0 | |
| TEW WILLIAM P PHD | Chief Commercial Officer | 3265 0.0064% | $0.45 | 0 | 5 | |
| SKIBSTED RUSSELL | Chief Financial Officer | 2000 0.0039% | $0.45 | 1 | 0 | |
| George Christopher Allen | SVP and CHIEF INFORMATION OFF | 600 0.0012% | $0.45 | 1 | 0 | |
| BERGER FRANKLIN M | director | 500 0.001% | $0.45 | 1 | 0 | |
| ELLIN ROBERT S | 10 percent owner | 421 0.0008% | $0.45 | 21 | 4 | <0.0001% |
| DENNY GEORGE P III | 10 percent owner | 3 0% | $0.45 | 3 | 1 | <0.0001% |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.